Top Smart Syringes Companies

Global Smart Syringes Market size was valued at USD 9.82 Billion in 2024 and is poised to grow from USD 10.59 Billion in 2025 to USD 19.31 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026–2033).

Global smart syringes market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global smart syringes market. For example, on 29 December 2020, Hindustan Syringes and Medical Devices (HMD), a medical disposables manufacturer, announced that it has increased production of Kojak auto-disable (AD) syringes, to meet the demand for the COVID vaccine. The company plans to increase production from 700 million Kojak Auto Disable (AD) syringes annually to one billion by June 2021. 'Becton, Dickinson and Company (BD) (USA) ', 'B. Braun Melsungen AG (Germany) ', 'Terumo Corporation (Japan) ', 'Medtronic plc (Ireland) ', 'Smiths Medical (UK) ', 'Cardinal Health, Inc. (USA) ', 'Gerresheimer AG (Germany) ', 'Nipro Corporation (Japan) ', 'Merit Medical Systems, Inc. (USA) ', 'Retractable Technologies, Inc. (USA) ', 'Revolution Medical Corporation (USA) ', 'Codan Ltd (Denmark) ', 'Baxter International Inc. (USA) ', 'ICU Medical, Inc. (USA) ', 'Hindustan Syringes & Medical Devices Limited (India) ', 'Schott AG (Germany) ', 'West Pharmaceutical Services, Inc. (USA) ', 'M.C. Johnson Company (USA) ', 'Changzhou Mingle Medical Equipment Co., Ltd. (China) ', 'Hi-Tech Syringes (India)'

As the prevalence of targeted diseases has increased, vaccination programs against targeted diseases have increased in various regions of the world. Also, the need to reduce hospital-acquired infections will drive the demand for smart syringes during the projection period. Smart syringes are in high demand due to the growing elderly population worldwide.

Smart syringes are generally used in vaccination, drug administration, and blood sampling, among which drug administration is the most common application area of ​​these syringes. Demand for Auto-disabled (AD) syringes from hospitals and HMOs has been at its highest for the past few years. These syringes find maximum use in the routine administration of drugs and fluids, due to which the demand for them is likely to remain high for the next few years. The use of the passive safety syringe segment is a key trend and is also expected to gain significant momentum in the coming years.

On the basis of region, global smart syringes market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America leads the global smart syringe market and accounts for more than 40% of the market revenue owing to growing need for modern healthcare technology. Also, greater awareness of blood-borne infections as a result of unsafe injection practices has increased the demand for smart syringes in North America. Also, the rising incidence of chronic diseases and the presence of a large number of elderly individuals in the region, along with rising healthcare costs, are driving the demand for smart syringes across North America.